Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Interleukin Genetics Incorporated - Financial and Strategic Analysis Review (Global Markets Direct)
- Market: Healthcare and Medical
- Published Date: 13/06/2009
- Report Title: Interleukin Genetics Incorporated - Financial and Strategic Analysis Review
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 18
Interleukin Genetics Incorporated - Financial and Strategic Analysis Review
Summary
Interleukin Genetics Incorporated (Interleukin) is a genetics-focused personalized health company engaged in the research, development, manufacture and sale of DNA based risk assessment tests for the personalized health markets. It offers innovative therapeutic products in two segments namely, Personalized Health segment and Consumer Products segment. It is the only company which has developed a DNA based risk assessment test to identify whether or not individuals have a genetic risk factor. It has strategic alliances with a large consumer products companies which market nutritional product designed for people who are tested positive for specific IL-1 genetic variations.
The Interleukin Genetics Incorporated - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Interleukin Genetics Incorporated. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Summary
Interleukin Genetics Incorporated (Interleukin) is a genetics-focused personalized health company engaged in the research, development, manufacture and sale of DNA based risk assessment tests for the personalized health markets. It offers innovative therapeutic products in two segments namely, Personalized Health segment and Consumer Products segment. It is the only company which has developed a DNA based risk assessment test to identify whether or not individuals have a genetic risk factor. It has strategic alliances with a large consumer products companies which market nutritional product designed for people who are tested positive for specific IL-1 genetic variations.
The Interleukin Genetics Incorporated - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Interleukin Genetics Incorporated. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
